Phenylethanolamine N-methyltransferase

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Current revision (09:24, 23 August 2023) (edit) (undo)
 
(16 intermediate revisions not shown.)
Line 1: Line 1:
-
[[Image:3kpj.jpg|left|200px|thumb|Crystal Structure of Phenylethanolamine N-methyltransferase [[3kpj]]]]
+
<StructureSection load='3hcb' size='450' side='right' caption='Human phenylethanolamine N-methyltransferase with adenosyl homocysteine complex with substrate noradrenochrome (PDB entry [[3hcb]])' scene='42/422437/Cv/3'>
-
{{STRUCTURE_3kpj| PDB=3kpj | SIZE=300| SCENE= |right|CAPTION=Phenylethanolamine N-methyltransferase with adenosyl homocysteine complex with phosphate ions [[3kpj]] }}
+
== Function ==
 +
[[Phenylethanolamine N-methyltransferase]] (PNMT) catalyzes the conversion of norepinephrine (noradrenaline) to epinephrine (adrenaline). This is the last step in the conversion of tyrosine to adrenaline<ref>PMID:11591352</ref>. S-adenosyl-L-homocysteine (AdoHcy) by itself or with other ligands are inhibitors of PNMT.
-
[[Phenylethanolamine N-methyltransferase]] (PNMT) catalyzes the conversion of norepinephrine (noradrenaline) to epinephrine (adrenaline). This is the last step in the conversion of tyrosine to adrenaline. S-adenosyl-L-homocysteine (AdoHcy) by itself or with other ligands are inhibitors of PNMT. The images at the left and at the right correspond to one representative PNMT, ''i.e.'' the crystal structure of Phenylethanolamine N-methyltransferase ([[3kpj]]).
+
==Relevance ==
 +
PNMT activity is decreased in Alzheimer disease patients<ref>PMID:3662456</ref>.
-
{{TOC limit|limit=2}}
+
== Structural highlights ==
 +
The active site of PNMT contains the <scene name='42/422437/Cv/8'>substrate</scene> and <scene name='42/422437/Cv/10'>AdoHcy</scene><ref>PMID:19570037</ref>. Water molecules are shown as red spheres. <scene name='42/422437/Cv/9'>Whole binding site</scene>.
 +
</StructureSection>
== 3D Structures of Phenylethanolamine N-methyltransferase ==
== 3D Structures of Phenylethanolamine N-methyltransferase ==
 +
 +
Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}}
[[3kpj]] – hPNMT+AdoHcy – human<br />
[[3kpj]] – hPNMT+AdoHcy – human<br />
-
[[3kpu]], [[3kpv]], [[3kpw]], [[3kpy]], [[3kqm]], [[3kqo]], [[3kqp]], [[3kqq]], [[3kqs]], [[3kqt]], [[3kqv]], [[3kqw]], [[3kqy]], [[3kr0]], [[3kr1]], [[3kr2]], [[3hcb]], [[3hcc]], [[3hcf]], [[2ony]], [[2g70]], [[2g71]], [[2g8n]], [[2an5]], [[1yz3]], [[1n7i]], [[1n7j]], [[1hnn]] - hPNMT+AdoHcy+ligand<br />
+
[[3kpu]], [[3kpv]], [[3kpw]], [[3kpy]], [[3kqm]], [[3kqo]], [[3kqp]], [[3kqq]], [[3kqs]], [[3kqt]], [[3kqv]], [[3kqw]], [[3kqy]], [[3kr0]], [[3kr1]], [[3kr2]], [[3hcb]], [[3hcc]], [[3hcf]], [[2ony]], [[2g70]], [[2g71]], [[2g8n]], [[2an5]], [[1yz3]], [[1n7i]], [[1n7j]], [[1hnn]], [[6ws1]], [[7two]], [[7tx2]] - hPNMT+AdoHcy+ligand<br />
[[3hca]], [[3hce]], [[2obf]], [[2onz]], [[2obp]] - hPNMT (mutant)+AdoHcy+ligand<br />
[[3hca]], [[3hce]], [[2obf]], [[2onz]], [[2obp]] - hPNMT (mutant)+AdoHcy+ligand<br />
[[3hcd]] - hPNMT+AdoHcy+noradrenaline<br />
[[3hcd]] - hPNMT+AdoHcy+noradrenaline<br />
[[2g72]] - hPNMT+AdoMet+ligand<br />
[[2g72]] - hPNMT+AdoMet+ligand<br />
 +
[[2opb]] - hPNMT+AdoMet + inhibitor<br />
[[2an3]] - hPNMT+AdoHcy+substrate analog<br />
[[2an3]] - hPNMT+AdoHcy+substrate analog<br />
-
[[2an4]] - hPNMT+AdoHcy+octopamine
+
[[2an4]] - hPNMT+AdoHcy+octopamine<br />
-
 
+
[[4dm3]] - hPNMT+AdoHcy + resorcinol + imidazole<br />
 +
[[4mik]], [[4mq4]] – hPNMT + inhibitor<br />
 +
== References ==
 +
<references/>
[[Category:Topic Page]]
[[Category:Topic Page]]

Current revision

Human phenylethanolamine N-methyltransferase with adenosyl homocysteine complex with substrate noradrenochrome (PDB entry 3hcb)

Drag the structure with the mouse to rotate

3D Structures of Phenylethanolamine N-methyltransferase

Updated on 23-August-2023

3kpj – hPNMT+AdoHcy – human
3kpu, 3kpv, 3kpw, 3kpy, 3kqm, 3kqo, 3kqp, 3kqq, 3kqs, 3kqt, 3kqv, 3kqw, 3kqy, 3kr0, 3kr1, 3kr2, 3hcb, 3hcc, 3hcf, 2ony, 2g70, 2g71, 2g8n, 2an5, 1yz3, 1n7i, 1n7j, 1hnn, 6ws1, 7two, 7tx2 - hPNMT+AdoHcy+ligand
3hca, 3hce, 2obf, 2onz, 2obp - hPNMT (mutant)+AdoHcy+ligand
3hcd - hPNMT+AdoHcy+noradrenaline
2g72 - hPNMT+AdoMet+ligand
2opb - hPNMT+AdoMet + inhibitor
2an3 - hPNMT+AdoHcy+substrate analog
2an4 - hPNMT+AdoHcy+octopamine
4dm3 - hPNMT+AdoHcy + resorcinol + imidazole
4mik, 4mq4 – hPNMT + inhibitor

References

  1. ↑ Martin JL, Begun J, McLeish MJ, Caine JM, Grunewald GL. Getting the adrenaline going: crystal structure of the adrenaline-synthesizing enzyme PNMT. Structure. 2001 Oct;9(10):977-85. PMID:11591352
  2. ↑ Burke WJ, Chung HD, Nakra BR, Grossberg GT, Joh TH. Phenylethanolamine N-methyltransferase activity is decreased in Alzheimer's disease brains. Ann Neurol. 1987 Aug;22(2):278-80. PMID:3662456 doi:http://dx.doi.org/10.1002/ana.410220216
  3. ↑ Drinkwater N, Gee CL, Puri M, Criscione KR, McLeish MJ, Grunewald GL, Martin JL. Molecular recognition of physiological substrate noradrenaline by the adrenaline-synthesizing enzyme PNMT and factors influencing its methyltransferase activity. Biochem J. 2009 Aug 27;422(3):463-71. PMID:19570037 doi:10.1042/BJ20090702

Proteopedia Page Contributors and Editors (what is this?)

Michal Harel, Alexander Berchansky

Retrieved from "http://52.214.119.220/wiki/index.php/Phenylethanolamine_N-methyltransferase"
Personal tools